We are not fixing anything using the GLP-1 ra drugs
Fourthly, lifestyle factors, such as diet, physical activity, smoking or other possible confounding risk factors affecting metabolism and fat accumulation, were not recorded in this study
The SURMOUNT-5 trial directly compared tirzepatide against semaglutide for obesity treatment, with tirzepatide achieving 20.2% weight loss versus 13.7% for semaglutide at their respective maximum tolerated doses
#DiabetesCare #MedTech #DigitalHealth #FreeStyleLibre #CGM #InsulinPump Executive Vice President, Abbott & President, Diabetes Care At #ATTD2026, we shared new data that shed light on the real challenges many people living with diabetes still face with rising diabetic ketoacidosis (DKA) rates and difficulties of ketone monitoring
However, medicines containing decongestants, Allegra-D, could increase your blood pressure and heart rate or interfere with your heart medication
The investigational triple agonist posted the largest trial weight loss ever reported, roughly 28 percent at 80 weeks, and the internet is full of misinformation about it
